U6 snRNA m6A modification is required for accurate and efficient cis- and trans-splicing of

C. elegans METT-10 RNA splicing SL trans-splicing SNRNP27K SNRP-27 U6 snRNA m6A modification

Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
16 Sep 2023
Historique:
pubmed: 25 9 2023
medline: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

pre-mRNA splicing is a critical feature of eukaryotic gene expression. Many eukaryotes use cis-splicing to remove intronic sequences from pre-mRNAs. In addition to cis-splicing, many organisms use trans-splicing to replace the 5' ends of mRNAs with a non-coding spliced-leader RNA. Both cis- and trans-splicing rely on accurately recognising splice site sequences by spliceosomal U snRNAs and associated proteins. Spliceosomal snRNAs carry multiple RNA modifications with the potential to affect different stages of pre-mRNA splicing. Here, we show that m6A modification of U6 snRNA A43 by the RNA methyltransferase METT-10 is required for accurate and efficient cis- and trans-splicing of

Identifiants

pubmed: 37745402
doi: 10.1101/2023.09.16.558044
pmc: PMC10516052
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : Cancer Research UK
ID : 27826
Pays : United Kingdom
Organisme : NIH HHS
ID : P40 OD010440
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA258589
Pays : United States
Organisme : Medical Research Council
ID : MR/S033769/1
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : R01 GM122960
Pays : United States

Auteurs

Aykut Shen (A)

School of Biological Sciences, University of East Anglia, NR4 7TJ, Norwich.

Katarzyna Hencel (K)

School of Biological Sciences, University of East Anglia, NR4 7TJ, Norwich.
These authors contributed equally.

Matthew T Parker (MT)

School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.
These authors contributed equally.

Robyn Scott (R)

Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Roberta Skukan (R)

School of Biological Sciences, University of East Anglia, NR4 7TJ, Norwich.

Aduragbemi S Adesina (AS)

School of Biological Sciences, University of East Anglia, NR4 7TJ, Norwich.

Carey L Metheringham (CL)

School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.

Eric A Miska (EA)

Wellcome/CRUK Gurdon Institute, University of Cambridge, Tennis Court Rd, Cambridge, CB2 1QN, UK.

Yunsun Nam (Y)

Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Wilfried Haerty (W)

School of Biological Sciences, University of East Anglia, NR4 7TJ, Norwich.
Earlham Institute, Norwich Research Park, Norwich, UK.

Gordon G Simpson (GG)

School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK.
Cell & Molecular Sciences, James Hutton Institute, Invergowrie, DD2 5DA, UK.

Alper Akay (A)

School of Biological Sciences, University of East Anglia, NR4 7TJ, Norwich.

Classifications MeSH